ANAGENICS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.006 AUD | -14.29% |
|
-14.29% | -68.42% |
| Mar. 08 | Anagenics Appoints CEO | MT |
| Feb. 26 | Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 9.23M 6.14M | Sales 2023 | 9.11M 6.06M | Capitalization | 6.22M 4.13M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -2M | Net income 2023 | -2M -1.33M | EV / Sales 2022 | 0.39 x |
| Net cash position 2022 | 1.53M 1.02M | Net cash position 2023 | 1.91M 1.27M | EV / Sales 2023 | 0.47 x |
| P/E ratio 2022 |
-1.32
x | P/E ratio 2023 |
-1.7
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.37% |
More Fundamentals
* Assessed data
More news
| 1 day | -14.29% | ||
| 1 week | -14.29% | ||
| Current month | -40.00% | ||
| 1 month | -33.33% | ||
| 3 months | -60.00% | ||
| 6 months | -68.42% | ||
| Current year | -68.42% |
1 week
0.01
0.01
1 month
0.010.01
Current year
0.010.02
1 year
0.010.03
3 years
0.010.07
5 years
0.010.49
10 years
0.010.88
| Managers | Title | Age | Since |
|---|---|---|---|
Matthew Dudek
DFI | Director of Finance/CFO | - | 19-12-31 |
Dominic Burg
COO | Chief Operating Officer | - | 16-02-29 |
Scott Greasley
BRD | Director/Board Member | - | 22-07-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sandy Beard
CHM | Chairman | 58 | 22-02-14 |
Karen Matthews
CEO | Chief Executive Officer | - | 23-02-13 |
| Director/Board Member | - | 21-11-04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 0.006 | -14.29% | 1 165 000 |
| 24-05-17 | 0.007 | 0.00% | 635,000 |
| 24-05-15 | 0.007 | 0.00% | 367,138 |
Delayed Quote Australian S.E., May 20, 2024 at 09:53 pm EDT
More quotes
Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Companyâs subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands.
Sector
Personal Products
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -68.42% | 2.16M | |
| +14.17% | 396B | |
| +12.76% | 143B | |
| +18.42% | 77.23B | |
| -12.61% | 65.65B | |
| -10.33% | 48.32B | |
| -7.57% | 39.2B | |
| +7.11% | 35.21B | |
| +11.84% | 18.31B | |
| +14.87% | 15.95B |
- Stock Market
- Equities
- AN1 Stock